| (11) | Number of the document | 4778 |
| (21) | Number of the application | a 2020 0088 |
| (22) | Filing date of the application | 2020.12.17 |
| | Date of filing the request for examination | (de fond) 18.03.2021 |
| (71) | Name(s) of applicant(s), code of the country | IP UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE "NICOLAE TESTEMITANU" DIN REPUBLICA MOLDOVA, MD; IP UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (72) | Name(s) of inventor(s), code of the country | GULEA Aurelian, MD; GRAUR Vasilii, MD; TAPCOV Victor, MD; GARBUZ Olga, MD; ANDRONACHE Lilia, MD; CEBAN Emil, MD; GUDUMAC Valentin, MD; |
| (73) | Name(s) of owner(s), code of the country | IP UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE "NICOLAE TESTEMITANU" DIN REPUBLICA MOLDOVA, MD; IP UNIVERSITATEA DE STAT DIN MOLDOVA, MD; |
| (54) | Title of the invention | Dichloro{methyl-N-(prop-2-en-1-yl)-2-[1-(pyridin-2-yl)ethylidene]hydrazinecarbimidothioate-N,N,N}copper compound, inhibiting the proliferation of human rhabdomyosarcoma cells |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | C07C 337/08 (2006.01); C07F 1/08 (2006.01); C07D 213/53 (2006.01); A61K 31/175 (2006.01); A61K 31/30 (2006.01); A61P 35/00 (2006.01); |
| (19) | Country | MD |
| (45) | Date of publication of patent granting decision: | 2021.12.31 |
| (47) | Date of issuance of patent | 2022.07.31 |
| | Substantive examiner(s) | GUŞAN Ala |
| | Payment for maintenance up to the date | 2025.12.17 |